Expression of the long non-coding RNA TCL6 is associated with clinical outcome in pediatric B-cell acute lymphoblastic leukemia

Blood Cancer J. 2019 Nov 25;9(12):93. doi: 10.1038/s41408-019-0258-9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor
  • Core Binding Factor Alpha 2 Subunit / genetics
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Male
  • Oncogene Proteins, Fusion / genetics
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / mortality*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Prognosis
  • RNA Interference*
  • RNA, Long Noncoding / genetics*

Substances

  • Biomarkers, Tumor
  • Core Binding Factor Alpha 2 Subunit
  • Oncogene Proteins, Fusion
  • RNA, Long Noncoding
  • TEL-AML1 fusion protein
  • long noncoding RNA TCL6, human